JP2011037901A5 - - Google Patents

Download PDF

Info

Publication number
JP2011037901A5
JP2011037901A5 JP2010261857A JP2010261857A JP2011037901A5 JP 2011037901 A5 JP2011037901 A5 JP 2011037901A5 JP 2010261857 A JP2010261857 A JP 2010261857A JP 2010261857 A JP2010261857 A JP 2010261857A JP 2011037901 A5 JP2011037901 A5 JP 2011037901A5
Authority
JP
Japan
Prior art keywords
compound
hydrochloride
tandospirone
buspirone
amd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010261857A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011037901A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011037901A publication Critical patent/JP2011037901A/ja
Publication of JP2011037901A5 publication Critical patent/JP2011037901A5/ja
Withdrawn legal-status Critical Current

Links

JP2010261857A 2000-03-17 2010-11-24 網膜外縁部障害の処置に有用な５−ｈｔ１ａ活性を有する化合物 Withdrawn JP2011037901A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19027900P 2000-03-17 2000-03-17

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001568420A Division JP4789231B2 (ja) 2000-03-17 2001-02-23 網膜外縁部障害の処置に有用な５−ｈｔ１ａ活性を有する化合物

Publications (2)

Publication Number Publication Date
JP2011037901A JP2011037901A (ja) 2011-02-24
JP2011037901A5 true JP2011037901A5 (https=) 2012-01-05

Family

ID=22700682

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2001568421A Pending JP2003527423A (ja) 2000-03-17 2001-02-20 緑内障処置用の５−ｈｔ２および５−ｈｔ１ａアゴニスト活性を有する化合物
JP2001568428A Withdrawn JP2003527427A (ja) 2000-03-17 2001-02-23 視野損失を抑制するのに有用な５−ｈｔ活性を有する化合物
JP2001568420A Expired - Fee Related JP4789231B2 (ja) 2000-03-17 2001-02-23 網膜外縁部障害の処置に有用な５−ｈｔ１ａ活性を有する化合物
JP2010261857A Withdrawn JP2011037901A (ja) 2000-03-17 2010-11-24 網膜外縁部障害の処置に有用な５−ｈｔ１ａ活性を有する化合物
JP2011108785A Withdrawn JP2011153158A (ja) 2000-03-17 2011-05-13 網膜外縁部障害の処置に有用な５−ｈｔ１ａ活性を有する化合物

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2001568421A Pending JP2003527423A (ja) 2000-03-17 2001-02-20 緑内障処置用の５−ｈｔ２および５−ｈｔ１ａアゴニスト活性を有する化合物
JP2001568428A Withdrawn JP2003527427A (ja) 2000-03-17 2001-02-23 視野損失を抑制するのに有用な５−ｈｔ活性を有する化合物
JP2001568420A Expired - Fee Related JP4789231B2 (ja) 2000-03-17 2001-02-23 網膜外縁部障害の処置に有用な５−ｈｔ１ａ活性を有する化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011108785A Withdrawn JP2011153158A (ja) 2000-03-17 2011-05-13 網膜外縁部障害の処置に有用な５−ｈｔ１ａ活性を有する化合物

Country Status (18)

Country Link
EP (3) EP1263434A1 (https=)
JP (5) JP2003527423A (https=)
KR (3) KR20030016239A (https=)
CN (2) CN1198605C (https=)
AR (1) AR028258A1 (https=)
AT (1) ATE247507T1 (https=)
AU (5) AU2001238552A1 (https=)
BR (3) BR0109193A (https=)
CA (3) CA2400637A1 (https=)
DE (1) DE60100625T2 (https=)
DK (1) DK1263504T3 (https=)
ES (1) ES2204848T3 (https=)
MX (3) MXPA02009071A (https=)
PL (1) PL203709B1 (https=)
PT (1) PT1263504E (https=)
TW (1) TWI268777B (https=)
WO (3) WO2001070223A1 (https=)
ZA (1) ZA200206350B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
US20030207890A1 (en) 2001-02-23 2003-11-06 Collier Robert J Compounds with 5-ht1a activity useful for treating disorders of the outer retina
MXPA02009071A (es) * 2000-03-17 2003-05-23 Alcon Inc Compuestos con actividad agonista de 5-ht 1a para tratar glaucoma..
TW593302B (en) * 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
CA2506204A1 (en) 2002-12-13 2004-07-01 Alcon, Inc. Novel benzopyran analogs and their use for the treatment of glaucoma
JP2004262812A (ja) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd 眼圧低下剤
JP4808612B2 (ja) * 2003-04-25 2011-11-02 田辺三菱製薬株式会社 アルキレンジオキシベンゼン誘導体を含む経口投与用組成物
US7476687B2 (en) 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
WO2005058911A2 (en) 2003-12-15 2005-06-30 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
JP5173190B2 (ja) 2004-08-25 2013-03-27 武田薬品工業株式会社 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
WO2006062839A1 (en) 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
WO2008117269A2 (en) 2007-03-28 2008-10-02 Atir Holding S.A. Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof
EP2727585A1 (en) 2006-05-16 2014-05-07 Takeda Pharmaceutical Company Limited In-vivo screening method
WO2008024846A2 (en) * 2006-08-25 2008-02-28 Allergan, Inc. Brimonidine and timolol compositions
EP2789338A3 (en) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Condensed pyridine derivate and use thereof
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
DK2498783T3 (en) 2009-11-09 2018-12-10 Allergan Inc COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc THERAPEUTICS FOR FIBROMYALGIA
EP2956096A1 (en) 2013-02-15 2015-12-23 Allergan, Inc. Sustained drug delivery implant
EP3519816A4 (en) 2016-09-29 2020-05-06 The Regents of the University of California CONNECTIONS FOR INCREASING NEURONAL PLASTICITY
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces
KR102946120B1 (ko) 2019-02-27 2026-03-30 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클
MX2021010198A (es) 2019-02-27 2021-09-21 Univ California Indoles n-sustituidos y otros heterociclos para el tratamiento de trastornos cerebrales.
IL313455A (en) 2021-12-15 2024-08-01 Delix Therapeutics Inc Phenoxy and benzyloxy modified psychroplastogens and their uses
EP4452267B1 (en) * 2021-12-23 2025-04-23 Cilcare Dev 4-phenyl-tetrahydropyridine derivatives for treating hearing diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02262518A (ja) * 1989-04-03 1990-10-25 Kaken Pharmaceut Co Ltd 眼圧調整剤
JP2824863B2 (ja) * 1989-07-12 1998-11-18 エーザイ株式会社 α▲下１▼―ブロッカー点眼剤
TW270114B (https=) * 1993-10-22 1996-02-11 Hoffmann La Roche
US5521183A (en) * 1994-08-30 1996-05-28 Allergan Use of 5-HT ligands as anti-pruritic agents
US5998467A (en) * 1995-10-25 1999-12-07 Mitsubishi Chemical Corporation Medicine for oculopathy
JP3958391B2 (ja) * 1995-10-25 2007-08-15 三菱化学株式会社 眼疾患用薬剤
AU4249297A (en) * 1996-10-31 1998-05-22 Alcon Laboratories, Inc. Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
GB9819033D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds VI
MXPA02009071A (es) * 2000-03-17 2003-05-23 Alcon Inc Compuestos con actividad agonista de 5-ht 1a para tratar glaucoma..

Similar Documents

Publication Publication Date Title
JP2011037901A5 (https=)
JP2012517962A5 (https=)
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
JP2013514381A5 (https=)
JP2012502885A5 (https=)
AR078766A1 (es) Formas solidas de n-(4-(7-azabiciclo(2.2.1) heptan-7-il)-2-( trifluorometil) fenil)-4-oxo-5-(trifluorometil)-1,4- dihidroquinolina-3-carboxamida
EA201891861A1 (ru) 2-(морфолин-4-ил)-1,7-нафтиридины
EA201500953A1 (ru) 3-ацетиламино-1-(фенилгетероариламинокарбонил или фенилгетероарилкарбониламино)бензольные производные для лечения гиперпролиферативных нарушений
JP2011518833A5 (https=)
WO2012016186A8 (en) Macrocyclic kinase inhibitors and uses thereof
JP2016501250A5 (https=)
JP2012092103A5 (https=)
JP2013508347A5 (https=)
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
CY1116791T1 (el) 4-αρυλ-ν-φαινυλ-1,3,5-τριαζιν-αμινες που περιεχουν μια ομαδα σουλφοξιμινης
JP2013532687A5 (https=)
PE20120989A1 (es) Sales de disacarina, acido difumarico, acido d-1-hidroxi-2-naftoico y monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino) pirimidin-5-il) metil) fenil) acetato de 4-(dimetilamino) butilo
JP2014513036A5 (https=)
WO2014209841A3 (en) Compounds for treating spinal muscular atrophy
MX343620B (es) Forma polimorfica de clorhidrato de pridopidina.
CN103717571B8 (zh) 9‑氨基甲基取代的四环素类化合物
JP2014505107A5 (https=)
WO2014093583A3 (en) Synthetic methods for preparing 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, other salt forms of this compound and intermediates thereof
GEP20166488B (en) Co-crystals and salts of ccr3-inhibitors
CL2012002540A1 (es) Hidrato de hidrocloruro de agomelatina; forma cristalina; metodo de preparacion; composicion farmaceutica ; y su uso para el tratamiento de trastornos del sueño, estrés, ansiedad, depresion mayor, enfermedades cardiovasculares, entre otras.